INDUCTION WITH TYROSINE KINASE INHIBITORS, CONSOLIDATION WITH FLUDARABINE, ARA-C AND DAUNOXOME FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANT IS AN EFFECTIVE AND FEASIBLE STRATEGY FOR PH+ ALL PATIENTS.

EHA Library, Nikki Di Felice, 180630

BONE MARROW MRD EVALUATION ON DAY 7 OF STEROID TREATMENT OF MODIFIED ST JUDE TOTAL XV THERAPY IN STANDART/LOW RISK PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Selin Aytac, 180631

PONATINIB (PON) IN PHILADELPHIA CHROMOSOME (PH)-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PRELIMINARY REPORT OF THE OPAL OBSERVATORY.

EHA Library, Suzanne Tavitian, 180632

JL1 ANTIGEN EXPRESSION OF LEUKEMIC CELLS IN CHILDHOOD ACUTE LEUKEMIA

EHA Library, Eunkyoung You, 180633

SERUM LEVELS OF CYTOKINES AND ADHESION MOLECULES AND THEIR ASSOCIATION WITH PROGNOSTIC FACTORS IN NEWLY DIAGNOSED ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Jan M Horacek, 180634

IMATINIB VS. DASATINIB FOR OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH PH+ ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Akio Shigematsu, 180635

IS OLDER AGE AN EXCLUSION CRITERION FOR ALLOGENEIC HEMOPOIETIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA?

EHA Library, Olga Aleshina Gavrilina, 180636

TARGETABLE BLINATUMOMAB + TYROSINE KINASE INHIBITORS TREATMENT IN RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS: CLINICAL EFFECTIVENESS AND PERIPHERAL LYMPHOCYTES SUBPOPULATIONS KINETICS.

EHA Library, Andrey Sokolov, 180637

VERY VERY LATE RELAPSES OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA, A CASE SERIES

EHA Library, Maria Nikita, 180638

NOVEL CRLF2 MUTATIONS AND CLINICAL SIGNIFICANCE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Chunhua song, 180639

THE MUTATIONAL SPECTRUM OF T(8;21)(Q22;Q22) POSITIVE ACUTE MYELOID LEUKEMIA DETERMINED BY HIGH-THROUGHPUT TARGETED SEQUENCING

EHA Library, Nikolaus Jahn, 180640

Bruton's Tyrosine Kinase and RAC1 pathways promote cell survival in MLL rearranged acute myeloid leukemia

EHA Library, Subbaiah chary Nimmagadda, 180641

A PRECISION MEDICINE PLATFORM FOR ACUTE MYELOID LEUKEMIA TO HELP UNRAVELING THE MOLECULAR ADDICTIONS OF FLT3-ITD-DRIVEN AML

EHA Library, Pilar Ayuda-Duran, 180642

SECRETION OF SOLUBLE FACTORS BY AML CELLS INFLUENCE CD33/CD3 BITE® ANTIBODY MEDIATED CYTOTOXICITY AND T-CELL PROLIFERATION

EHA Library, Martina Costanzi, 180643

CLONAL EVOLUTION OF FLT3-ITD POSITIVE AML AT DIAGNOSIS AND RELAPSE IN PATIENTS TREATED WITHIN THE CALGB 10603 (RATIFY) AND AMLSG 16-10 TRIALS

EHA Library, Laura Schmalbrock, 180644

MICROENVIRONMENT SECRETED PROTEINS MEDIATE RESISTANCE TO TARGETED THERAPY IN PRIMARY AML CELLS

EHA Library, Arran Dokal, 180645

CHARACTERIZATION OF FLT3 MUTATIONS AT DIAGNOSIS, REFRACTORY DISEASE OR RELAPSE IN AML PATIENTS TREATED WITH MIDOSTAURIN WITHIN THE CALGB 10603 (RATIFY) AND AMLSG 16-10 TRIALS

EHA Library, Laura Schmalbrock, 180646

A NOVEL PML-RARG FUSION IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Jung Sook Ha, 180647

COOPERATION OF MLL-PTD WITH DNMT3A OR RUNX1 MUTATIONS IN AML LEUKEMOGENESIS

EHA Library, Hsiao-Wen Kao, 180648

AML BLASTS INDUCE A SENESCENT PHENOTYPE IN THE BM-MSC THROUGH THE UPREGULATION OF P21

EHA Library, Eoghan Forde, 180649

HYPOXIA DRIVES AML PROLIFERATION IN THE TUMOR MICROENVIRONMENT THROUGH HIF1Α/MIF SIGNALLING

EHA Library, Amina Abdul-Aziz, 180650

BONE MARROW ECOLOGICAL COLLAPSE IN ACUTE MYELOID LEUKEMIA IS MEDIATED BY REMODELING OF ENDOSTEAL VESSELS

EHA Library, Delfim Duarte, 180651

CLONAL HETEROGENEITY IN PATIENT-DERIVED XENOGRAFT OF ADULT ACUTE MYELOID LEUKAEMIA

EHA Library, Fanny Gonzales, 180652

COSTIMULATION INCREASES INTRACELLULAR SIGNALLING IN BITE® ANTIBODY CONSTRUCT MEDIATED T-CELL ACTIVATION

EHA Library, Lavinia Pachzelt, 180653

ESTABLISHING SINGLE CELL WHOLE EXOME SEQUENCING ANALYSIS AS A DISCOVERY TOOL IN NPM1/FLT3 POSITIVE PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Christiane Walter, 180654

RAF KINASE INHIBITOR PROTEIN IS INVOLVED IN THE DEVELOPMENT OF MYELOID SARCOMA

EHA Library, Veronica Caraffini, 180655

INHIBITING MIR-10A OVERCOMES CYTARABINE-RESISTANCE IN ACUTE MYELOID LEUKAEMIA

EHA Library, Thi Thanh Vu, 180656

BY AN MCL-1-DEPENDENT MECHANISM, ALVOCIDIB POTENTIATES THE ACTIVITY OF CYTARABINE AND MITOXANTRONE WHEN ADMINISTERED IN A TIME SEQUENTIAL REGIMEN IN AML

EHA Library, Steven Warner, 180657

DYSREGULATION IN KEY REGULATOR GENES OF AUTOPHAGY AS A MECHANISM OF THERAPY RESISTANCE AND POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM MICROARRAY ANALYSIS ON 148 PATIENTS

EHA Library, Maria Chiara Fontana, 180658

NO EVIDENCE FOR MICROSATELLITE INSTABILITY (MSI) IN 1,394 PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Christopher Walker, 180659

SY-1425, A POTENT AND SELECTIVE RARΑ AGONIST, REPROGRAMS AML CELLS FOR DIFFERENTIATION ALONG DISTINCT LINEAGES, UNCOVERING PD MARKERS FOR CLINICAL STUDIES

EHA Library, Michael McKeown, 180660

GENETIC CHARACTERIZATION OF A LARGE GROUP OF CEBPA MUTATED AML PATIENTS AND THE EFFECT OF TET2 AND GATA2 MUTATIONS ON OUTCOME

EHA Library, Nikola Konstandin, 180661

MECHANISMS OF SYK-MEDIATED SUPPRESSION OF DIFFERENTIATION AND APOPTOSIS IN ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Anna Polak, 180662

MUTATIONAL PROFILE OF RELAPSE-RISK GROUPS IN ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS

EHA Library, M. Isabel Prieto-Conde, 180663

ANALYSIS OF THE PD-1/PD-L1 AXIS POINTS TO ASSOCIATION OF UNFAVORABLE RECURRENT MUTATIONS WITH PD-L1 EXPRESSION IN AML

EHA Library, Krzysztof Giannopoulos, 180664

DISSECTING THE DYNAMICS OF SINGLE-TUMOR-CELL-LINEAGES THAT UNDERPIN RELAPSE OF AML

EHA Library, Haakan Norell, 180665

MRD ANALYSIS BY NEXT-GENERATION SEQUENCING APPROACH FOR ACUTE MYELOID LEUKEMIA FOLLOW-UP

EHA Library, Maria Esther Onecha Fuente, 180667

THE ROLE OF MYELOID-DERIVED SUPPRESSOR CELLS-LIKE BLASTS WHICH SUPPRESS T CELL PROLIFERATION IN LEUKEMIC CELL GROWTH

EHA Library, Shin Young Hyun, 180668

GENERATION OF NEW CELLULAR MODELS FOR THE STUDY OF PEDIATRIC NON DOWN SYNDROME ACUTE MEGAKARYOBLASTIC LEUKEMIA BASED ON HUMAN PLURIPOTENT STEM CELLS

EHA Library, Joan Domingo Reinés, 180669

CHARACTERIZATION OF HEMATOLOGIC MALIGNANCIES WITH ANCHORED MULTIPLEX PCR AND NEXT-GENERATION SEQUENCING

EHA Library, Darius Fugere, 180670

ASXL1 MUTATIONS IN AML ARE ASSOCIATED WITH SPECIFIC CLINICAL AND CYTOGENETIC CHARACTERISTICS

EHA Library, Vasiliki Pappa, 180671

A COMPREHENSIVE DNA TEST FOR THE DETECTION OF TRANSLOCATIONS IN ACUTE LEUKEMIA

EHA Library, Eva Van Den Berg-De Ruiter, 180673

ALTERATIONS IN NECROPTOSIS PATHWAY AFFECT PROGNOSIS OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Silvia Lo Monaco, 180674

NGS ANALYSIS AND IMPACT OF VARIANT ALLELIC FREQUENCY AT RELAPSE AND REFRACTORINESS STATUS IN AML PATIENTS

EHA Library, Maria Esther Onecha Fuente, 180675

PRECLINICAL EVIDENCE THAT TRAMETINIB ENHANCES THE RESPONSE TO TYROSINE KINASE INHIBITORS IN ACUTE MYELOID LEUKEMIA

EHA Library, Maria Luz Morales, 180676

IDENTIFICATION OF NOVEL THERAPEUTIC DRUGS IN DISTINCT PEDIATRIC AML SUBTYPES BY TARGETING EPIGENETIC REGULATORS

EHA Library, Caroline Wiggers, 180677

ALVOCIDIB SYNERGIZES WITH CYTARABINE AND DAUNORUBICIN (7+3) IN PRECLINICAL MODELS OF ACUTE MYELOID LEUKEMIA

EHA Library, Steven Warner, 180678

COMBINATION OF INTERFERON-ALPHA AND VALPROIC ACID IN ACUTE MYELOID LEUKEMIA CELLS IN VITRO AND IN VIVO

EHA Library, Bjorn T. Gjertsen, 180679

KEVETRIN: PRECLINICAL STUDY OF A NEW COMPOUND IN ACUTE MYELOID LEUKEMIA

EHA Library, Serena De Matteis, 180680

CLEARANCE OF ‘DRIVER-COSMIC’ MUTATIONS POST CR1 WITH PERSISTING RUNX1_L56S IS UNLIKELY TO CONTRIBUTE TOWARDS DISEASE PROGRESSION IN AML

EHA Library, Lena Rai, 180681

PROGNOSTIC SIGNIFICANCE OF FLT3 STATUS, CYTOGENETIC, ECOG AND 50% BLAST DECREASE IN PRIMARY REFRACTORY OR EARLY RELAPSED AML PATIENTS BEFORE SALVAGE THERAPY.

EHA Library, Etienne Paubelle, 180682

PRELIMINARY RESULTS FROM A PHASE 1 STUDY EXAMINING THE NOVEL BCL-2 INHIBITOR S55746/BCL201 AS SINGLE AGENT IN PATIENTS WITH ACUTE MYELOID LEUKEMIA OR HIGH RISK MYELODYSPLASTIC SYNDROME

EHA Library, Andrew H. Wei, 180683

DISSECTING THE CLINICAL HETEROGENEITY OF NUCLEOPHOSMIN-1 (NPM1) MUTATED ADULT ACUTE MYELOID LEUKEMIA : THE CONTRIBUTION OF FLOW-CYTOMETRIC DETERMINATION OF MINIMAL RESIDUAL DISEASE

EHA Library, Francesco Buccisano, 180684

EXPRESSION OF IMMUNE CHECKPOINT MOLECULES (PD-1, PD-L1, AND PD-L2) ON BONE MARROW T CELLS IN ACUTE MYELOID LEUKEMIA

EHA Library, Eunkyoung You, 180685

ACUTE LEUKEMIA IN HIV PATIENTS : EPIDEMIOLOGY, THERAPEUTIC STRATEGY AND PROGNOSIS

EHA Library, Emmanuel Raffoux, 180686

TEN-DAY DECITABINE AS INDUCTION THERAPY FOR OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA FIT FOR INTENSIVE CHEMOTHERAPY

EHA Library, Hui Wei, 180687

INDOXIMOD IN COMBINATION WITH IDARUBICIN AND CYTARABINE FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): PHASE 1 REPORT

EHA Library, Ashkan Emadi, 180688

PHASE I/II STUDY OF MEK INHIBITOR (MEK-162; BINIMETINIB) IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MYELOID MALIGNANCIES

EHA Library, Kiran Naqvi, 180689

HAPLOIDENTICAL TRANSPLANTATION IS SAFE AND EFFECTIVE FOR OLDER PATIENTS WITH AML/MDS

EHA Library, Stefan Ciurea, 180690

OPTIMIZATION OF MINIMAL RESIDUAL DISEASE EVALUATION IN ACUTE MYELOID LEUKEMIA TO DRIVE POST REMISSION THERAPY

EHA Library, Paola Minetto, 180691

THE NUMBER OF CD34+CD38+CD117+HLA-DR+CD13+CD33+ CELLS INDICATES POST-CHEMOTHERAPY NEUTROPHIL RECOVERY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Yuntao Liu, 180692

MICRORNAS (MIRS) IN HIGH RISK PEDIATRIC ACUTE MYELOID LEUKEMIA (AML) AS PREDICTION TOOLS FOR RELAPSE INCIDENCE

EHA Library, Pier Paolo Leoncini, 180693

CYTOKINE RECEPTORS AND SOLUBLE ADHESION MOLECULE LEVELS ARE ASSOCIATED WITH PROGNOSIS OF NEWLY DIAGNOSED AML

EHA Library, Jan M Horacek, 180694

MRD-DRIVEN CHOICE OF CONSOLIDATION AND MODULATION OF INDUCTION AND CONSOLIDATION INTENSITY RESULTED IN A SIGNIFICANTLY IMPROVED OUTCOME OF YOUNGER AML PATIENTS IN THE LAST THREE YEARS

EHA Library, Marino Clavio, 180695

EFFECTIVENESS OF TREATMENT ACUTE MYELOID LEUKEMIA IN THE ELDERLY USING CLADRIBINE WITH LOW-DOSE ARAC

EHA Library, M Watek, 180696

SMALL CUSTOMIZABLE NGS BASED TARGET CAPTURE PANELS DETECT VARIANTS IN CLINICAL SPECIMENS AT FREQUENCIES AS LOW AS 0.5%

EHA Library, Lisa Chamberlain, 180697

EFFICACY BY OUTPATIENT VS INPATIENT ADMINISTRATION OF CONSOLIDATION: SUBGROUP ANALYSIS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED, HIGH-RISK ACUTE MYELOID LEUKEMIA

EHA Library, Jonathan Kolitz, 180698

MOLECULAR GENETIC TESTING PATTERNS FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) ENROLLED IN THE CONNECT® MDS/AML DISEASE REGISTRY

EHA Library, Daniel Pollyea, 180699

PHASE 1, OPEN-LABEL, RANDOMIZED STUDY TO EVALUATE THE EFFECT OF CYTOCHROME P450 (CYP) 3A4 INHIBITION ON THE PHARMACOKINETICS (PK) AND SAFETY OF QUIZARTINIB (Q) AND ITS ACTIVE METABOLITE, AC886

EHA Library, Jianke Li, 180700

SYSTEMATIC LITERATURE REVIEW AND INDIRECT COMPARISON OF GLASDEGIB PLUS LOW DOSE ARA-C VERSUS A HYPOMETHYLATING AGENT FOR ACUTE MYELOID LEUKEMIA PATIENTS INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Anna Forsythe, 180701

CLINICAL OUTCOMES OF CHILDHOOD ACUTE MEGAKARYOBLASTIC LEUKEMIA: THE CHILDREN CANCER HOSPITAL EGYPT 57357 EXPERIENCE

EHA Library, Noura maarouf, 180702

IDENTIFICATION OF RESISTANCE ASSOCIATED CPG METHYLATION CHANGES IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING INDUCTION CHEMOTHERAPY

EHA Library, Christian Niederwieser, 180703

OVER-EXPRESSION OF ZEB2-AS1 LNCRNA PREDICTS POOR OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Xiaolan Shi, 180704

INTENSIFICATION OF ANTHRACYCLINE DURING INDUCTION AND CONSOLIDATION IS SAFE AND WELL TOLERATED IN OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA

EHA Library, Shaun Fleming, 180705

PROGNOSTIC IMPACT OF IDH1 AND IDH2 MUTATIONS IN LOW AND INTERMEDIATE RISK AML: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Marcello Riva, 180706

DECITABINE COMBINED WITH HAAG REGIMEN IS AN EFFECTIVE SALVAGE TREATMENT FOR ADVANCED ACUTE MYELOID LEUKEMIA

EHA Library, Xiaowen Tang, 180707

LESS-INTENSIVE TREATMENT LEADS TO DECREASED SURVIVAL IN UNMARRIED ACUTE MYELOID LEUKEMIA PATIENTS AND PATIENTS LIVING ALONE. A DANISH NATIONAL POPULATION-BASED COHORT STUDY

EHA Library, Lene Sofie Granfeldt Østgård, 180708

TREATMENT OF MOLECULAR RELAPSE IN ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1 REDUCES TOXICITY OF SALVAGE TREATMENT AND IMPROVES DISEASE CLEARANCE

EHA Library, Fabio Guolo, 180709

MINIMAL RESIDUAL DISEASE AND LAIP CHANGES BY FLOW CYTOMETRY IN DE NOVO ACUTE MYELOID LEUKEMIA DURING CHEMOTHERAPY AND CLINICAL OUTCOMES

EHA Library, Tatiana Lobanova, 180710

LENALIDOMIDE MAINTENANCE IN PATIENTS WITH HIGH RISK ACUTE MYELOID LEUKEMIA

EHA Library, Tapan Kadia, 180711

POSTREMISSION THERAPY FOR AML WITH INTERMEDIATE RISK CYTOGENETICS IN FIRST COMPLETE REMISSION

EHA Library, Jan Vydra, 180712

LONG TERM FOLLOW UP OF PATIENTS OVER 60 YEARS TREATED WITH INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES

EHA Library, Sabine Blum, 180713

FLAG-IDA FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA: A SINGLE CENTRE 5-YEAR STUDY

EHA Library, Charles AGBUDUWE, 180714

A MULTICENTER, RETROSPECTIVE ANALYSIS OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA WHO WERE TREATED WITH DECITABINE

EHA Library, Jun Ho Yi, 180715

DRUG-DRUG INTERACTION POTENTIAL OF GILTERITINIB IN HEALTHY SUBJECTS AND PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Mark Levis, 180716

A FLUDARABINE-BASED ACUTE MYELOID LEUKEMIA INDUCTION IS WELL TOLERATED UP TO 75Y OF AGE ALLOWS EARLY CONSOLIDATION AND LONG TERM SURVIVAL. A SINGLE CENTRE EXPERIENCE OF 136 CONSECUTIVE PATIENTS

EHA Library, Monica Bocchia, 180717

OVEREXPRESSION OF SOX4 CORRELATEDS WITH POOR PROGNOSIS OF ACUTE MYELOID LEUKEMIA

EHA Library, Chung-Yi Hu, 180718

AN OPEN-LABEL, MULTICENTER, PROSPECTIVE, RANDOMIZED STUDY OF RECOMBINANT HUMAN THROMBOPOIETIN AS AN ADJUNCT AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA

EHA Library, Xiao-Hui Sui, 180719

TREATMENT-ASSOCIATED SURVIVAL RATES IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): A SYSTEMATIC LITERATURE REVIEW

EHA Library, Jill Bell, 180720

SYSTEMATIC REVIEW OF HEALTH STATE UTILITY VALUES FOR ECONOMIC EVALUATION OF ACUTE MYELOID LEUKEMIA

EHA Library, Anna Forsythe, 180721

ITALIAN REAL LIFE EXPERIENCE OF DECITABINE IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS: INTERIM ANALYSIS OF MULTICENTRIC OBSERVATIONAL DEA65 STUDY.

EHA Library, Lara Aprile, 180722

ASPARAGINASE ERWINIA CHRYSANTHEMI EFFECTIVELY DEPLETES PLASMA GLUTAMINE, HAS CLINICAL ACTIVITY, AND IS WELL TOLERATED IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Ashkan Emadi, 180723

PROGNOSTIC SIGNIFICANCE OF SOX2, SOX3, SOX11, SOX14 AND SOX18 GENE EXPRESSION IN DE NOVO ACUTE MYELOID LEUKEMIA (AML) PATIENTS

EHA Library, Natasa Tosic, 180724

ACUTE ANTHRACYCLINE INDUCED CARDIOTOXICITY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Oren Pasvolsky, 180725

AN INTEGER WEIGHTED GENOMIC MUTATION SCORING (IWGMS) USING THE TRUSIGHT MYELOID SEQUENCING PANEL SHOWS HIGHER MORTALITY IN PATIENTS WITH INTERMEDIATE RISK ACUTE MYELOID LEUKEMIA- A RETROSPECTIVE STUDY

EHA Library, Qian (Janie) Qin, 180726

SUCCESSFUL IDENTIFICATION OF SPECIFIC AMINO ACID-DEPENDENCE IN ADULT T-CELL LEUKEMIA / LYMPHOMA (ATL) AND PRECLINICAL APPLICATION FOR NEW THERAPY

EHA Library, Tomohiro Ishigaki, 180727

BONE MARROW BIOPSY SUPERIORITY OVER PET/CT IN PREDICTING PROGRESSION FREE SURVIVAL IN A HOMOGENOUSLY-TREATED COHORT OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Tzu-Hua Chen Liang, 180729

THE PROGNOSTIC SIGNIFICANCE OF CD11B+CX3CR1+ MONOCYTES IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Jae-Yong Kwak, 180730

RARE NON-HODGKIN LYMPHOMAS (R-NHLS) IN CHILDREN: THE AIEOP EXPERIENCE

EHA Library, Davide Massano, 180731

PRIMARY ANALYSIS OF THE EFFECT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE TREATMENT OF 110 CASES OF T CELL LYMPHOMA

EHA Library, Caixia Li, 180732